Roberto Lanzi

Biography

Dr. Roberto Lanzi is the head of the Internal Medicine and Specialty Day Hospital at IRCCS Ospedale San Raffaele.

After graduating in Medicine and Surgery in 1987 from the University of Milan, he specialized first in Internal Medicine in 1992, and later in Endocrinology in 1996. During his training, he worked as a Research Fellow at the Neuropeptide Physiology Laboratory of the Montreal Children's Hospital Research Institute, McGill University, Montreal, Quebec, Canada.

Dr. Lanzi’s clinical interest has always been focused on diseases of the endocrine system, with particular reference to dysfunctions of the pituitary gland, adrenal gland, and thyroid. He performs thyroid ultrasound and cytodiagnostics. In the field of thyroidology, since 2018, he has contributed to the implementation of radiofrequency therapy for the treatment of benign thyroid nodules and collaborates with the multidisciplinary thyroid oncology clinic. He also provides endocrine support to women being treated at the Center for Reproductive Sciences.

In 2010, he opened the Internal Medicine and Specialty Day Hospital, where he is currently the head physician.

Dr. Lanzi is the San Raffaele Hospital representative for the Regional Network of Rare Diseases and the European Endo-ERN network for rare adult endocrine diseases. He is also a member of the following scientific societies: the Endocrine Society, the Italian Society of Endocrinology (SIE), the Association of Endocrinologists (AME), the Italian Society of Ultrasound in Medicine and Biology (SIUMB), and the International Hair Research Foundation (IHRF).

He is the author of several articles published in international scientific journals and of numerous chapters in endocrinology books.

Read moreRead less

Education

University of Milan
Degree in Medicine and Surgery - 1987

University of Milan
Specialization in Internal Medicine - 1992

University of Milan
Specialization in Experimental Endocrinology - 1996

Do you need an appointment?

Contact us and we will take care of you.

Publications

Latest publications

Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release
Endocrinology, 1992, 130: 780-788.
R. Lanzi, G.S. Tannenbaum
Read more
Time-dependent reduction and potentiation of GH responsiveness to GH-releasing factor induced by exogenous GH; role for somatostatin.
Endocrinology, 1992, 130: 1822-1828.
R. Lanzi, G.S. Tannenbaum
Read more
Evidence of a primary role for somatostatin in mediating clonidine-induced growth hormone release in conscious rats.
J. Endocrinol., 1994, 141: 259-266.
R. Lanzi, M. Lapointe, W. Gurd, G.S. Tannenbaum.
Read more
Growth hormone (GH) metabolic clearance rate, half life and volume of distribution in acromegalic patients: assessment by combined GH and octreotide infusions.
J. Clin. Endocrinol. Metab., 1995, 80: 3279-3283.
R. Lanzi, A.C. Andreotti, A. Caumo, M.F. Manzoni, M. Losa, M.E. Malighetti, A.E. Pontiroli
Read more
Restoration of growth hormone (GH) response to GHreleasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Clin. Endocrinol. Metab., 1996, 81: 3998-4001
A.E. Pontiroli, M.F. Manzoni, M.E. Malighetti, R. Lanzi
Read more
Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone(GH) response to GH-releasing hormone (GHRH) in healthy subjects.
J. Clin. Endocrinol. Metab.,1997, 82: 2239-2243.
R. Lanzi, M.F. Manzoni, M.E. Malighetti, A.C. Andreotti, E. Bianchi, L. Piceni Sereni, L. Luzi, A.E. Pontiroli.
Read more
Laparoscopic bilateral adrenalectomy for persistent Cushing’s disease after transsphenoidal surgery.
Surgery, 1998, 123: 144-150.
R. Lanzi, G. Guazzoni, F. Montorsi, M. Losa, A. Centemero, M.F. Manzoni, P. Rigatti, G. Cornaggia, A.E. Pontiroli.
Read more
The control on growth hormone (GH) release by free fatty acids is maintained in acromegaly.
Endocrinol: Metab., 1999, 84 (4): 1234-1238
R. Lanzi, M. Losa, G. Mignogna, A. Caumo, A.E. Pontiroli.
Read more
Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Metabolism, 1999, 48 (9): 1152-1156.
R. Lanzi, L. Luzi, A. Caumo, A.C. Andreotti, M.F. Manzoni, M.E. Malighetti, L. Piceni Sereni, A.E. Pontiroli.
Read more
GH replacement therapy increases blood osteoprotegerin levels in GH deficient adults.
European Journal of Endocrinology, 2003, 148: 185-191.
R. Lanzi, M. Losa, I. Villa, E. Gatti, M. Sirtori, C. Dal Fiume, A. Rubinacci
Read more
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency.
Thyroid, 2008, 18 (12):1249-54.
M. Losa, M. Scavini, E. Gatti, A. Rossini, S. Madaschi, I. Formenti, A. Caumo, C. A. Stidley, R. Lanzi.
Read more
Treatment of thyroid-associated orbithopathy with Rituximab: a novel therapy for an old disease. Case report and literature review.
Endocr. Pract., 2010, 16 (4): 677-685
S. Madaschi, A. Rossini, I. Formenti, V. Lampasona, S. Bianchi Marzoli, G. Cammarata, L.S. Politi, V. Martinelli, E. Bazzigaluppi, M. Scavini, E. Bosi, R. Lanzi
Read more
Magnetic Resonance Imaging with Diffusion Weighted Imaging in the evaluation of Thyroid-Associated Orbitopathy: getting below the tip of the iceberg.
European Radiol, 2014, Eur Radiol. 2014 May;24(5):1118-26.
L.S. Politi, C. Godi, C. Cammarata, A. Ambrosi, A. Iadanza, R. Lanzi, A. Falini, S. Bianchi Marzoli.
Read more
Ovarian hyperstimulation syndrome due to folliclestimulating hormone-secreting pituitary adenomas.
Pituitary 2017, 20 (5): 553-560.
A. Caretto, R. Lanzi, C. Piani, M. Molgora, P. Mortini, M. Losa.
Read more
Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency.
Growth Hormone & IGF Research 2019, 46–47: 50–54
F. De Cobelli, A. Rossini, a. Esposito, T. Canu, G. Manzoni, a. Del Maschio, M. Sirtori, M. Losa, R. Lanzi, G. Perseghin.
Read more

Do you need an appointment?

Contact us and we will take care of you.